INSYS Therapeutics Files to Withdraw IPO Plans

NEW YORK, Sept 8 (Reuters) - U.S. biopharmaceutical company Insys Therapeutics Inc filed to withdraw its plans for an $86.3 million initial public offering, citing market conditions.
MORE ON THIS TOPIC